Welcome to LookChem.com Sign In|Join Free
  • or
Tert-Butyl (3S,4R)-4(3-Fluorophenyl)pyrrolidin-3-ylcarbaMate is a chemical compound with the molecular formula C17H25FN2O2. It is a pyrrolidinylcarbamic acid derivative, featuring a tert-butyl group and a 3-fluorophenyl group. tert-Butyl (3S,4R)-4(3-Fluorophenyl)pyrrolidin-3-ylcarbaMate is a potential drug candidate with pharmaceutical applications due to its ability to interact with specific receptors or enzymes within the body. The exact mechanism of action and specific therapeutic uses of Tert-Butyl (3S,4R)-4(3-Fluorophenyl)pyrrolidin-3-ylcarbaMate are currently under investigation and development.

1260596-09-5

Post Buying Request

1260596-09-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1260596-09-5 Usage

Uses

Used in Pharmaceutical Industry:
Tert-Butyl (3S,4R)-4(3-Fluorophenyl)pyrrolidin-3-ylcarbaMate is used as a potential drug candidate for its ability to interact with specific receptors or enzymes in the body. Its precise mechanism of action and specific therapeutic uses are still being studied and developed, making it a promising compound for various pharmaceutical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1260596-09-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,5,9 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1260596-09:
(9*1)+(8*2)+(7*6)+(6*0)+(5*5)+(4*9)+(3*6)+(2*0)+(1*9)=155
155 % 10 = 5
So 1260596-09-5 is a valid CAS Registry Number.

1260596-09-5Upstream product

1260596-09-5Relevant academic research and scientific papers

PYRROLIDINYL UREA DERIVATIVES AND APPLICATION THEREOF IN TRKA-RELATED DISEASES

-

Paragraph 0188; 0193; 0194, (2021/05/21)

The present invention relates to a class of TrkA inhibitors and an application thereof in the preparation of a drug for the treatment of diseases associated with TrkA. The present invention specifically discloses compounds represented by formula (I) and f

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1260596-09-5